Clinical trials
Hyperphosphatemia Patients on Hemodialysis clinical trials
Below are recruiting hyperphosphatemia patients on hemodialysis clinical trials, each written for real people, not researchers. We’re tracking 5 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07285291RecruitingPhase 3
Study of a new drug for high phosphorus in dialysis patients
This trial tests a new medicine called TS-172 for people with high phosphorus levels who are on hemodialysis. It aims to lower phosphorus levels and is taken along with your current phosphate binder medication.
TokyoAges 18 years+ - NCT07548840RecruitingPhase 3
Testing TS-172 to lower phosphorus in dialysis patients
This study tests a new medication called TS-172 for people on dialysis whose phosphorus levels stay high despite taking other phosphorus-lowering drugs. The goal is to see if TS-172 can better control phosphorus and help prevent bone and heart problems that high phosphorus causes.
TokyoAges 18 years+ - NCT07285304RecruitingPhase 3
Long-term study of TS-172 for high phosphorus on dialysis
This trial tests a new medicine, TS-172, to lower high phosphorus levels in people with kidney disease who are on hemodialysis. It looks at safety and effectiveness over a longer period.
TokyoAges 18 years+ - NCT06664125RecruitingPhase 2
New drug for high phosphorus in dialysis patients
This trial tests a new drug, JMKX003002, to lower high phosphorus levels in people with end-stage kidney disease who are on hemodialysis. If you have trouble controlling your phosphorus, this treatment might help.
Guangzhou, GuangdongAges 18 years+ - NCT06406140Enrolling by invitationPhase 2/Phase 3
Niacin for cholesterol and phosphate in dialysis patients
This study tests whether a vitamin called niacin can help lower a type of cholesterol (Lp(a)) and reduce high phosphate levels in people on hemodialysis. It may offer a new way to improve heart and bone health for dialysis patients.
CairoAges 18 years+
Hear when a new Hyperphosphatemia Patients on Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hyperphosphatemia patients on hemodialysis?
- Yes. Clin2 currently lists 5 recruiting hyperphosphatemia patients on hemodialysis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hyperphosphatemia patients on hemodialysis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hyperphosphatemia patients on hemodialysis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.